IRX Therapeutics' approach to fighting cancer and viral diseases focuses on stimulating a coordinated TH1-specific cellular immune response.
This approach is unique because it drives an effective cellular immune response via antigen presentation and T-cell activation, while also enhancing humoral immune response.
IRX Therapeutics' approach to fighting cancer and viral diseases focuses on stimulating a coordinated TH1-specific cellular immune response.